Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|42|4|418-427

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.42, Iss.4, 2015-08, pp. : 418-427

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: gut‐directed hypnotherapy or low FODMAP diet for the treatment of irritable bowel syndrome?

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 44, Iss. 8, 2016-10 ,pp. : 901-902

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical effectiveness and economic costs of group versus one‐to‐one education for short‐chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome

By  

JOURNAL OF HUMAN NUTRITION & DIETETICS (ELECTRONIC), Vol. 28, Iss. 6, 2015-12 ,pp. : 687-696

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: irritable bowel syndrome—how a low‐FODMAP diet or yoga might help

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 3, 2018-02 ,pp. : 444-445

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: irritable bowel syndrome—how a low‐FODMAP diet or yoga might help. Authors’ reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 3, 2018-02 ,pp. : 445-446

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dietary practices and FODMAPs in South Asia: Applicability of the low FODMAP diet to patients with irritable bowel syndrome

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 33, Iss. 2, 2018-02 ,pp. : 365-374

John Wiley & Sons Inc

Access to resources Recommend Favorite